OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Alk-Abello A/S ALK-ABELLO B ORD S.../  DK0061802139  /

London International
5/3/2024  6:40:14 PM Chg. 0.00 Volume Bid5/3/2024 Ask5/3/2024 Market Capitalization Dividend Y. P/E Ratio
149.45DKK 0.00% 6,879
Turnover: 968,541.50		 -Bid Size: - -Ask Size: - 32.81 bill.DKK - 97.89
GlobeNewswire 5/2 Three-month interim report (Q1) 2024 (unaudited) 
GlobeNewswire 2/16 Annual General Meeting in ALK-Abelló A/S on 14 March 2024
GlobeNewswire 2/8 Annual report 2023: ALK delivers 9% sales growth with profits up 50%
GlobeNewswire 2/5 ALK’s 2030 CO2 reduction targets have been approved by SBTi
GlobeNewswire 1/18 ALK completes first part of phase 1 trial with peanut SLIT-tablet
GlobeNewswire 11/15/2023 Nine-month interim report (Q3) 2023
GlobeNewswire 8/24/2023 Six-month interim report (Q2) 2023
GlobeNewswire 3/3/2022 Clinical trial waiver in China opens door to 2022 registration filing for ALK’s dust mite allergy ta...
GlobeNewswire 2/21/2022 Annual General Meeting in ALK-Abelló A/S on 16 March 2022
GlobeNewswire 2/8/2022 Annual report 2021: ALK delivers strong sales growth of 12% with tablet sales up 29% and EBITDA up 3...
GlobeNewswire 8/11/2021 Six-month interim report (Q2) 2021
GlobeNewswire 8/9/2021 ALK upgrades its full-year financial outlook
GlobeNewswire 8/4/2021 Otonomy Reports Second Quarter 2021 Financial Results and Provides Corporate Update
GlobeNewswire 7/30/2021 ALK and Grandpharma team up to market the first adrenaline autoinjector in China
GlobeNewswire 5/11/2021 Otonomy Reports First Quarter 2021 Financial Results and Provides Corporate Update
GlobeNewswire 2/11/2021 Otonomy Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
GlobeNewswire 2/10/2021 ALK releases 2020 annual report
GlobeNewswire 11/11/2020 Nine-month interim report (Q3) 2020
GlobeNewswire 11/5/2020 ALK updates its full-year financial outlook
GlobeNewswire 8/12/2020 Six-month interim report (Q2) 2020
GlobeNewswire 8/4/2020 Otonomy Reports Second Quarter 2020 Financial Results and Provides Corporate Update
GlobeNewswire 6/15/2020 Otonomy Provides Update on Clinical Trials and Development Programs
GlobeNewswire 5/6/2020 Three-month interim report (Q1) 2020
GlobeNewswire 2/5/2020 ALK releases its 2019 annual report
GlobeNewswire 9/13/2019 Change of Chairman at ALK